No Data
No Data
Chimerix Shares Top 52-week Highs, Company Plans FDA Submission of Cancer Drug Dordaviprone
CervoMed CRVO Phase 2b Fails; Chimerix SNDA Application
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Sector Update: Health Care Stocks Decline Late Afternoon
Sector Update: Health Care
Top Midday Gainers
No Data